Status:
COMPLETED
A Observational Study to Compare Effectiveness and Safety of the Surgeries in Patients With Esophageal Cancer
Lead Sponsor:
Chinese PLA General Hospital
Collaborating Sponsors:
LinkDoc Technology (Beijing) Co. Ltd.
Conditions:
Esophageal Cancer
Eligibility:
All Genders
Brief Summary
The study was designed to compare effectiveness and safety of the surgeries of Ivor-Lewis and Mckeown in patients with esophageal cancer
Detailed Description
The trial is a multi-centre real-world non-interventional observational study. The study was designed to compare effectiveness and safety of the minimally invasive surgeries of Ivor-Lewis and Mckeown ...
Eligibility Criteria
Inclusion
- Pathologically diagnosed middle and lower thoracic IA-IIIB esophageal cancer after surgeries;
- Patients who received minimally invasive radical dissections of Ivor-Lewis and Mckeown;
- Patients who received tubular gastroesophageal reconstruction;
Exclusion
- Patients complicated with arrhythmia, or serious disfunctions of heart, lung, liver, and kidney before surgeries;
- Patients with second primary tumors;
- Patients who received abdominal or thoracic surgeries;
- Patients who received gastrostomy or nesteostomy before surgeries;
- Patients with suspected cervical lymph metastases (in the subgroup of the patients who received the surgery of Mckeown)
Key Trial Info
Start Date :
December 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2018
Estimated Enrollment :
1862 Patients enrolled
Trial Details
Trial ID
NCT03428074
Start Date
December 1 2017
End Date
March 30 2018
Last Update
May 21 2018
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
China-Japan Friendship Hospital
Beijing, Beijing Municipality, China, 100029
2
Henan cancer hospital
Zhengzhou, Henan, China, 450008
3
Tongji Hospital Affiliated to Huazhong Technology Hospital
Wuhan, Hubei, China, 430030
4
Jiangsu Cancer Hospital
Nanjing, Jiangsu, China, 210009